Selected research
Industry Research
Peritoneal Dialysis Formulations Industry Research Report 2026
Market perspective
The global Peritoneal Dialysis Formulations market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Peritoneal Dialysis Formulations is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Peritoneal Dialysis Formulations is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Peritoneal Dialysis Formulations is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Peritoneal Dialysis Formulations include Baxter, Fresenius, B. Braun, WEGO, Huaren Pharmaceutical, CR Double-Crane, Qingshan Likang, SSY Group and Wuhu Daorun Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Peritoneal Dialysis Formulations market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Peritoneal Dialysis Formulations Market by Company
Baxter
Fresenius
B. Braun
WEGO
Huaren Pharmaceutical
CR Double-Crane
Qingshan Likang
SSY Group
Wuhu Daorun Pharmaceuticals
Pharmasyntez Group
Peritoneal Dialysis Formulations Segment by Type
Glucose-based Peritoneal Dialysis Solution
Amino Acid-based Peritoneal Dialysis Solution
Icodextrin Peritoneal Dialysis Solution
Peritoneal Dialysis Formulations Segment by Application
Hospital
Clinic
Dialysis Center
Peritoneal Dialysis Formulations Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peritoneal Dialysis Formulations market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peritoneal Dialysis Formulations and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peritoneal Dialysis Formulations.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Peritoneal Dialysis Formulations manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Peritoneal Dialysis Formulations by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Peritoneal Dialysis Formulations in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Glucose-based Peritoneal Dialysis Solution
- Amino Acid-based Peritoneal Dialysis Solution
- Icodextrin Peritoneal Dialysis Solution
Applications
- Hospital
- Clinic
- Dialysis Center
Companies covered
- Baxter
- Fresenius
- B. Braun
- WEGO
- Huaren Pharmaceutical
- CR Double-Crane
- Qingshan Likang
- SSY Group
- Wuhu Daorun Pharmaceuticals
- Pharmasyntez Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Peritoneal Dialysis Formulations Market Size (2021-2032)
- 2.2.2 Global Peritoneal Dialysis Formulations Sales (2021-2032)
- 2.2.3 Global Peritoneal Dialysis Formulations Market Average Price (2021-2032)
- 2.3 Peritoneal Dialysis Formulations by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Glucose-based Peritoneal Dialysis Solution
- 2.3.3 Amino Acid-based Peritoneal Dialysis Solution
- 2.3.4 Icodextrin Peritoneal Dialysis Solution
- 2.4 Peritoneal Dialysis Formulations by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Dialysis Center
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Peritoneal Dialysis Formulations Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Peritoneal Dialysis Formulations Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Peritoneal Dialysis Formulations Revenue of Manufacturers (2021-2026)
- 3.4 Global Peritoneal Dialysis Formulations Average Price by Manufacturers (2021-2026)
- 3.5 Global Peritoneal Dialysis Formulations Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Peritoneal Dialysis Formulations, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Peritoneal Dialysis Formulations, Product Type & Application
- 3.8 Global Manufacturers of Peritoneal Dialysis Formulations, Established Date
- 3.9 Global Peritoneal Dialysis Formulations Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Baxter
- 4.1.1 Baxter Company Information
- 4.1.2 Baxter Business Overview
- 4.1.3 Baxter Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Baxter Peritoneal Dialysis Formulations Product Portfolio
- 4.1.5 Baxter Recent Developments
- 4.2 Fresenius
- 4.2.1 Fresenius Company Information
- 4.2.2 Fresenius Business Overview
- 4.2.3 Fresenius Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fresenius Peritoneal Dialysis Formulations Product Portfolio
- 4.2.5 Fresenius Recent Developments
- 4.3 B. Braun
- 4.3.1 B. Braun Company Information
- 4.3.2 B. Braun Business Overview
- 4.3.3 B. Braun Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 B. Braun Peritoneal Dialysis Formulations Product Portfolio
- 4.3.5 B. Braun Recent Developments
- 4.4 WEGO
- 4.4.1 WEGO Company Information
- 4.4.2 WEGO Business Overview
- 4.4.3 WEGO Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 WEGO Peritoneal Dialysis Formulations Product Portfolio
- 4.4.5 WEGO Recent Developments
- 4.5 Huaren Pharmaceutical
- 4.5.1 Huaren Pharmaceutical Company Information
- 4.5.2 Huaren Pharmaceutical Business Overview
- 4.5.3 Huaren Pharmaceutical Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Huaren Pharmaceutical Peritoneal Dialysis Formulations Product Portfolio
- 4.5.5 Huaren Pharmaceutical Recent Developments
- 4.6 CR Double-Crane
- 4.6.1 CR Double-Crane Company Information
- 4.6.2 CR Double-Crane Business Overview
- 4.6.3 CR Double-Crane Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 CR Double-Crane Peritoneal Dialysis Formulations Product Portfolio
- 4.6.5 CR Double-Crane Recent Developments
- 4.7 Qingshan Likang
- 4.7.1 Qingshan Likang Company Information
- 4.7.2 Qingshan Likang Business Overview
- 4.7.3 Qingshan Likang Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Qingshan Likang Peritoneal Dialysis Formulations Product Portfolio
- 4.7.5 Qingshan Likang Recent Developments
- 4.8 SSY Group
- 4.8.1 SSY Group Company Information
- 4.8.2 SSY Group Business Overview
- 4.8.3 SSY Group Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 SSY Group Peritoneal Dialysis Formulations Product Portfolio
- 4.8.5 SSY Group Recent Developments
- 4.9 Wuhu Daorun Pharmaceuticals
- 4.9.1 Wuhu Daorun Pharmaceuticals Company Information
- 4.9.2 Wuhu Daorun Pharmaceuticals Business Overview
- 4.9.3 Wuhu Daorun Pharmaceuticals Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Wuhu Daorun Pharmaceuticals Peritoneal Dialysis Formulations Product Portfolio
- 4.9.5 Wuhu Daorun Pharmaceuticals Recent Developments
- 4.10 Pharmasyntez Group
- 4.10.1 Pharmasyntez Group Company Information
- 4.10.2 Pharmasyntez Group Business Overview
- 4.10.3 Pharmasyntez Group Peritoneal Dialysis Formulations Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Pharmasyntez Group Peritoneal Dialysis Formulations Product Portfolio
- 4.10.5 Pharmasyntez Group Recent Developments
5 Global Peritoneal Dialysis Formulations Market Scenario by Region
- 5.1 Global Peritoneal Dialysis Formulations Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Peritoneal Dialysis Formulations Sales by Region: 2021-2032
- 5.2.1 Global Peritoneal Dialysis Formulations Sales by Region: 2021-2026
- 5.2.2 Global Peritoneal Dialysis Formulations Sales by Region: 2027-2032
- 5.3 Global Peritoneal Dialysis Formulations Revenue by Region: 2021-2032
- 5.3.1 Global Peritoneal Dialysis Formulations Revenue by Region: 2021-2026
- 5.3.2 Global Peritoneal Dialysis Formulations Revenue by Region: 2027-2032
- 5.4 North America Peritoneal Dialysis Formulations Market Facts & Figures by Country
- 5.4.1 North America Peritoneal Dialysis Formulations Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Peritoneal Dialysis Formulations Sales by Country (2021-2032)
- 5.4.3 North America Peritoneal Dialysis Formulations Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Peritoneal Dialysis Formulations Market Facts & Figures by Country
- 5.5.1 Europe Peritoneal Dialysis Formulations Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Peritoneal Dialysis Formulations Sales by Country (2021-2032)
- 5.5.3 Europe Peritoneal Dialysis Formulations Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Peritoneal Dialysis Formulations Market Facts & Figures by Country
- 5.6.1 Asia Pacific Peritoneal Dialysis Formulations Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Peritoneal Dialysis Formulations Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Peritoneal Dialysis Formulations Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Peritoneal Dialysis Formulations Market Facts & Figures by Country
- 5.7.1 South America Peritoneal Dialysis Formulations Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Peritoneal Dialysis Formulations Sales by Country (2021-2032)
- 5.7.3 South America Peritoneal Dialysis Formulations Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Peritoneal Dialysis Formulations Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Peritoneal Dialysis Formulations Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Peritoneal Dialysis Formulations Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Peritoneal Dialysis Formulations Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Peritoneal Dialysis Formulations Sales by Type (2021-2032)
- 6.1.1 Global Peritoneal Dialysis Formulations Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Peritoneal Dialysis Formulations Sales Market Share by Type (2021-2032)
- 6.2 Global Peritoneal Dialysis Formulations Revenue by Type (2021-2032)
- 6.2.1 Global Peritoneal Dialysis Formulations Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Peritoneal Dialysis Formulations Revenue Market Share by Type (2021-2032)
- 6.3 Global Peritoneal Dialysis Formulations Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Peritoneal Dialysis Formulations Sales by Application (2021-2032)
- 7.1.1 Global Peritoneal Dialysis Formulations Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Peritoneal Dialysis Formulations Sales Market Share by Application (2021-2032)
- 7.2 Global Peritoneal Dialysis Formulations Revenue by Application (2021-2032)
- 7.2.1 Global Peritoneal Dialysis Formulations Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Peritoneal Dialysis Formulations Revenue Market Share by Application (2021-2032)
- 7.3 Global Peritoneal Dialysis Formulations Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Peritoneal Dialysis Formulations Value Chain Analysis
- 8.1.1 Peritoneal Dialysis Formulations Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Peritoneal Dialysis Formulations Production Mode & Process
- 8.2 Peritoneal Dialysis Formulations Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Peritoneal Dialysis Formulations Distributors
- 8.2.3 Peritoneal Dialysis Formulations Customers
9 Global Peritoneal Dialysis Formulations Analyzing Market Dynamics
- 9.1 Peritoneal Dialysis Formulations Industry Trends
- 9.2 Peritoneal Dialysis Formulations Industry Drivers
- 9.3 Peritoneal Dialysis Formulations Industry Opportunities and Challenges
- 9.4 Peritoneal Dialysis Formulations Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst